GRI Bio (GRI) announced the appointment of Leanne Kelly as its Chief Financial Officer. Prior to her appointment at GRI Bio, Kelly served as the Chief Financial Officer of Vallon Pharmaceuticals (VLON), which recently announced the completion of its merger with GRI Bio.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on VLON:
- GRI Bio announces board of director appointments
- Vallon Pharmaceuticals Completes Merger with GRI Bio, Inc.
- Vallon Pharmaceuticals completes merger with GRI Bio
- Vallon Pharmaceuticals Announces Stockholder Approval of Merger with GRI Bio, Inc. and Reverse Stock Split
- Vallon Pharmaceuticals stockholders approve GRI Bio merger, reverse stock split
